Literature DB >> 32241845

Excellent proliferation and persistence of allogeneic donor-derived 41-BB based CAR-T cells despite immunosuppression with cyclosporine A.

Francis Ayuk1, Boris Fehse2, Dietlinde Janson2, Carolina Berger2, Kristoffer Riecken2, Nicolaus Kröger2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 32241845      PMCID： PMC7271598          DOI： 10.3324/haematol.2019.245969

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  15 in total

1.  Efficacy and toxicity of low-dose escalating donor lymphocyte infusion given after reduced intensity conditioning allograft for multiple myeloma.

Authors:  F Ayuk; A Shimoni; A Nagler; R Schwerdtfeger; M Kiehl; H G Sayer; T Zabelina; A R Zander; N Kröger
Journal:  Leukemia       Date:  2004-03       Impact factor: 11.528

2.  Intent-to-treat leukemia remission by CD19 CAR T cells of defined formulation and dose in children and young adults.

Authors:  Rebecca A Gardner; Olivia Finney; Colleen Annesley; Hannah Brakke; Corinne Summers; Kasey Leger; Marie Bleakley; Christopher Brown; Stephanie Mgebroff; Karen S Kelly-Spratt; Virginia Hoglund; Catherine Lindgren; Assaf P Oron; Daniel Li; Stanley R Riddell; Julie R Park; Michael C Jensen
Journal:  Blood       Date:  2017-04-13       Impact factor: 22.113

3.  Donor CD19 CAR T cells exert potent graft-versus-lymphoma activity with diminished graft-versus-host activity.

Authors:  Arnab Ghosh; Melody Smith; Scott E James; Marco L Davila; Enrico Velardi; Kimon V Argyropoulos; Gertrude Gunset; Fabiana Perna; Fabiana M Kreines; Emily R Levy; Sophie Lieberman; Hillary V Jay; Andrea Z Tuckett; Johannes L Zakrzewski; Lisa Tan; Lauren F Young; Kate Takvorian; Jarrod A Dudakov; Robert R Jenq; Alan M Hanash; Ana Carolina F Motta; George F Murphy; Chen Liu; Andrea Schietinger; Michel Sadelain; Marcel R M van den Brink
Journal:  Nat Med       Date:  2017-01-09       Impact factor: 53.440

4.  Phase I trials using Sleeping Beauty to generate CD19-specific CAR T cells.

Authors:  Partow Kebriaei; Harjeet Singh; M Helen Huls; Matthew J Figliola; Roland Bassett; Simon Olivares; Bipulendu Jena; Margaret J Dawson; Pappanaicken R Kumaresan; Shihuang Su; Sourindra Maiti; Jianliang Dai; Branden Moriarity; Marie-Andrée Forget; Vladimir Senyukov; Aaron Orozco; Tingting Liu; Jessica McCarty; Rineka N Jackson; Judy S Moyes; Gabriela Rondon; Muzaffar Qazilbash; Stefan Ciurea; Amin Alousi; Yago Nieto; Katy Rezvani; David Marin; Uday Popat; Chitra Hosing; Elizabeth J Shpall; Hagop Kantarjian; Michael Keating; William Wierda; Kim Anh Do; David A Largaespada; Dean A Lee; Perry B Hackett; Richard E Champlin; Laurence J N Cooper
Journal:  J Clin Invest       Date:  2016-08-02       Impact factor: 14.808

5.  Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma.

Authors:  Sattva S Neelapu; Frederick L Locke; Nancy L Bartlett; Lazaros J Lekakis; David B Miklos; Caron A Jacobson; Ira Braunschweig; Olalekan O Oluwole; Tanya Siddiqi; Yi Lin; John M Timmerman; Patrick J Stiff; Jonathan W Friedberg; Ian W Flinn; Andre Goy; Brian T Hill; Mitchell R Smith; Abhinav Deol; Umar Farooq; Peter McSweeney; Javier Munoz; Irit Avivi; Januario E Castro; Jason R Westin; Julio C Chavez; Armin Ghobadi; Krishna V Komanduri; Ronald Levy; Eric D Jacobsen; Thomas E Witzig; Patrick Reagan; Adrian Bot; John Rossi; Lynn Navale; Yizhou Jiang; Jeff Aycock; Meg Elias; David Chang; Jeff Wiezorek; William Y Go
Journal:  N Engl J Med       Date:  2017-12-10       Impact factor: 91.245

6.  Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation.

Authors:  R H Collins; O Shpilberg; W R Drobyski; D L Porter; S Giralt; R Champlin; S A Goodman; S N Wolff; W Hu; C Verfaillie; A List; W Dalton; N Ognoskie; A Chetrit; J H Antin; J Nemunaitis
Journal:  J Clin Oncol       Date:  1997-02       Impact factor: 44.544

7.  One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.

Authors:  E D Thomas; C D Buckner; M Banaji; R A Clift; A Fefer; N Flournoy; B W Goodell; R O Hickman; K G Lerner; P E Neiman; G E Sale; J E Sanders; J Singer; M Stevens; R Storb; P L Weiden
Journal:  Blood       Date:  1977-04       Impact factor: 22.113

8.  Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia.

Authors:  Shannon L Maude; Theodore W Laetsch; Jochen Buechner; Susana Rives; Michael Boyer; Henrique Bittencourt; Peter Bader; Michael R Verneris; Heather E Stefanski; Gary D Myers; Muna Qayed; Barbara De Moerloose; Hidefumi Hiramatsu; Krysta Schlis; Kara L Davis; Paul L Martin; Eneida R Nemecek; Gregory A Yanik; Christina Peters; Andre Baruchel; Nicolas Boissel; Francoise Mechinaud; Adriana Balduzzi; Joerg Krueger; Carl H June; Bruce L Levine; Patricia Wood; Tetiana Taran; Mimi Leung; Karen T Mueller; Yiyun Zhang; Kapildeb Sen; David Lebwohl; Michael A Pulsipher; Stephan A Grupp
Journal:  N Engl J Med       Date:  2018-02-01       Impact factor: 91.245

9.  Graft-versus-leukemia effect of donor lymphocyte transfusions in marrow grafted patients.

Authors:  H J Kolb; A Schattenberg; J M Goldman; B Hertenstein; N Jacobsen; W Arcese; P Ljungman; A Ferrant; L Verdonck; D Niederwieser; F van Rhee; J Mittermueller; T de Witte; E Holler; H Ansari
Journal:  Blood       Date:  1995-09-01       Impact factor: 22.113

10.  Adoptive immunotherapy evaluating escalating doses of donor leukocytes for relapse of chronic myeloid leukemia after bone marrow transplantation: separation of graft-versus-leukemia responses from graft-versus-host disease.

Authors:  S Mackinnon; E B Papadopoulos; M H Carabasi; L Reich; N H Collins; F Boulad; H Castro-Malaspina; B H Childs; A P Gillio; N A Kernan
Journal:  Blood       Date:  1995-08-15       Impact factor: 22.113
View more
  8 in total

Review 1.  Efficacy and safety of CD19 CAR-T cell therapy for acute lymphoblastic leukemia patients relapsed after allogeneic hematopoietic stem cell transplantation.

Authors:  Pei-Hua Lu; Kai-Yan Liu; Xing-Yu Cao; Jing-Jing Li
Journal:  Int J Hematol       Date:  2022-06-23       Impact factor: 2.319

2.  Optimized NGFR-derived hinges for rapid and efficient enrichment and detection of CAR T cells in vitro and in vivo.

Authors:  A Bister; T Ibach; C Haist; G Gerhorst; D Smorra; M Soldierer; K Roellecke; M Wagenmann; K Scheckenbach; N Gattermann; C Wiek; H Hanenberg
Journal:  Mol Ther Oncolytics       Date:  2022-06-06       Impact factor: 6.311

3.  Directed Evolution of Stabilized Monomeric CD19 for Monovalent CAR Interaction Studies and Monitoring of CAR-T Cell Patients.

Authors:  Elisabeth Laurent; Anna Sieber; Benjamin Salzer; Anna Wachernig; Jacqueline Seigner; Manfred Lehner; René Geyeregger; Bernhard Kratzer; Ulrich Jäger; Renate Kunert; Winfried F Pickl; Michael W Traxlmayr
Journal:  ACS Synth Biol       Date:  2021-04-12       Impact factor: 5.249

Review 4.  How to Combine the Two Landmark Treatment Methods-Allogeneic Hematopoietic Stem Cell Transplantation and Chimeric Antigen Receptor T Cell Therapy Together to Cure High-Risk B Cell Acute Lymphoblastic Leukemia?

Authors:  Mingming Zhang; He Huang
Journal:  Front Immunol       Date:  2020-12-15       Impact factor: 7.561

Review 5.  Engineering CAR T cells for enhanced efficacy and safety.

Authors:  Yiqian Wu; Ziliang Huang; Reed Harrison; Longwei Liu; Linshan Zhu; Yinglin Situ; Yingxiao Wang
Journal:  APL Bioeng       Date:  2022-01-18

6.  A novel CD34-derived hinge for rapid and efficient detection and enrichment of CAR T cells.

Authors:  Arthur Bister; Tabea Ibach; Corinna Haist; Denise Smorra; Katharina Roellecke; Martin Wagenmann; Kathrin Scheckenbach; Norbert Gattermann; Constanze Wiek; Helmut Hanenberg
Journal:  Mol Ther Oncolytics       Date:  2021-11-11       Impact factor: 7.200

7.  Monitoring of Circulating CAR T Cells: Validation of a Flow Cytometric Assay, Cellular Kinetics, and Phenotype Analysis Following Tisagenlecleucel.

Authors:  Andreas Peinelt; Melanie Bremm; Hermann Kreyenberg; Claudia Cappel; Julia Banisharif-Dehkordi; Stephanie Erben; Eva Rettinger; Andrea Jarisch; Roland Meisel; Paul-Gerhardt Schlegel; Olaf Beck; Gesine Bug; Jan-Henning Klusmann; Thomas Klingebiel; Sabine Huenecke; Peter Bader
Journal:  Front Immunol       Date:  2022-03-02       Impact factor: 7.561

8.  Comparison of single copy gene‑based duplex quantitative PCR and digital droplet PCR for monitoring of expansion of CD19‑directed CAR T cells in treated patients.

Authors:  Maria-Luisa Schubert; Carolina Berger; Alexander Kunz; Anita Schmitt; Anita Badbaran; Brigitte Neuber; Silke Zeschke; Lei Wang; Kristoffer Riecken; Angela Hückelhoven-Krauss; Ingo Müller; Carsten Müller-Tidow; Peter Dreger; Nicolaus Kröger; Francis A Ayuk; Michael Schmitt; Boris Fehse
Journal:  Int J Oncol       Date:  2022-03-16       Impact factor: 5.650
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.